Scientists from Binghamton University; Brigham and Women’s Hospital; Yizheng Hospital of the Nanjing Drum Tower Hospital Group in China; and Heidelberg University Hospital in Germany are researching the use of cell-derived nanovesicles to deliver therapeutic agents to the interior of cancer cells with better accuracy and efficiency. By identifying overexpressed or cancer-specific antigens that occur in malignant cells and targeting the nanovesicles, encapsulated drugs were injected into cancer cells while leaving healthy cells alone.
An official website of the United States government.